iotaMotion, Inc.

Advancing CI Surgery: Robotic Precision for Electrode Array Insertion.

iotaMotion is standardizing CI electrode array insertion with iotaSOFT®, an open-platform robotic-assisted electrode array insertion system compatible with all three CI manufacturers. By controlling insertion at speeds beyond human capability, the iotaSOFT System can reduce surgical variability and intracochlear trauma—addressing several key patient concerns.

Clinical Evidence: The iotaSOFT Advantage
A landmark study in The Laryngoscope (Khan et al., 2026) highlights the clinical superiority of robotic-assisted insertion over manual techniques for long-term hearing outcomes.

Key Findings at One-Year Post-Op:

• Superior Preservation: 85% of the robotic-assisted group maintained functional acoustic hearing, compared to 71% in the manual group.
  Enhanced Stability: Robotic insertion reduced Delayed-Onset Hearing Loss (DOHL) by nearly one-third, suggesting that precise, controlled insertion mitigates long-term intracochlear trauma.

Why It Matters for Audiologists
As candidacy expands, robotic assistance helps bridge the gap for the 60 million individuals worldwide with severe-to-profound impairment who may fear losing residual natural hearing.

• Manufacturer Agnostic: Compatible with all three major CI manufacturers.
• Proven Scale: Utilized in over 1,300 cases across 35+ centers nationwide.
• Expanded Access: Now FDA-cleared for patients ages four and older.

By utilizing the iotaSOFT Insertion System, clinics can offer a more predictable physiological outcome, directly addressing some of the primary barriers to CI adoption. Please visit our website, review our Clinical Evidence Summary or reach out to us at: [email protected].

*World Health Organization (WHO). iotaMotion Data on File.